Effects of Breathıng Exercıses wıth Vırtual Realıty Glasses on Anxıety Levels, Sleep Qualıty and Respıratory Parameters in Heart Faılure Patıents
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 45
- Locations
- 2
- Primary Endpoint
- Anxiety level
Study Overview
Brief Summary
Anxiety and sleep disorders are among the most common symptoms in heart failure patients. In addition to pharmacological methods for anxiety and sleep disorders, non-pharmacological methods can also be used. Among these, anxiety and sleep disorders can be prevented with virtual reality glasses aimed at distraction. This study will be conducted to evaluate the effect of breathing exercises performed with virtual reality glasses on anxiety, sleep quality, and respiratory parameters. The study will be conducted with a total of 45 patients, 15 virtual reality glasses + breathing exercises, 15 breathing exercises, and 15 controls. Those in the virtual reality glasses + breathing exercises group will perform breathing exercises with virtual reality glasses once a day for 7 days. Those in the breathing exercises group will perform only breathing exercises once a day for 7 days. Anxiety, sleep disorders, and respiratory parameters of the patients will be examined.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •18 years of age or older,
- •Verbal communication,
- •Place and time oriented,
- •Without any psychiatric illness,
- •Patients diagnosed with HF with NYHA class III-IV symptoms,
- •Left ventricular ejection fraction ≥50% (LVEF-CF/HFpEF), between 40-49% (SEF-CF/HFmrEF), HF below 40% (DEF-CF/HFrEF),
- •High levels of natriuretic peptides (BNP>35 pg/mL and/or NTproBNP>125 pg/mL),
- •There is no deformity or diagnosis related to the musculoskeletal system that may prevent breathing exercise,
- •Chronic diseases such as hypertension (Stage 1 and 2 HT) and diabetes mellitus are stable and the treatment for these diagnoses has not been changed in the last month,
- •Who have not previously received respiratory exercise training and have not participated in a rehabilitation program,
- •Patients who volunteer to participate in the study will be included in the study
Exclusion Criteria
- •Life signs are so abnormal as to preclude intervention,
- •Patients with migraine, vertigo, active nausea-vomiting, headache, dizziness will not be included in the study.
Arms & Interventions
Virtual reality glasses + breathing exercise app
Virtual reality glasses + breathing exercise app
Intervention: breathing exercise (Behavioral)
Virtual reality glasses + breathing exercise app
Virtual reality glasses + breathing exercise app
Intervention: Virtual reality glasses (Behavioral)
Breathing exercise practice
Breathing exercise practice
Intervention: breathing exercise (Behavioral)
Kontrol
No application will be made
Outcomes
Primary Outcomes
Anxiety level
Time Frame: Apply the morning before application and the morning 7 days after application.
Turkish adaptation of the state-trait anxiety inventory short version (STAIS-5, STAIT-5). This form is a 4-point Likert type. It is an easy-to-apply inventory consisting of a total of 10 statements. As the score obtained in this form increases, the level of anxiety also increases.
Secondary Outcomes
- Sleep Quality(Apply the morning before application and the morning 7 days after application.)
Investigators
Servet KALYONCUO
Research Assistant
Bayburt University